Genetic Pathways, Part 2
December 29, 2015|Cutis
Author and Disclosure Information
As part of our commitment to resident education, Cutis is excited to offer this monthly section with board-relevant, easy-to-review material.
This fact sheet details some of the important tumor suppressor pathways in dermatology and the clinical manifestations seen with these genetic derangements.
3. Which of the following would least likely be seen in neurofibromatosis types 1 or 2?
a. angiofibromas
b. café au lait macules
,c. gliomas
d. Lisch nodules
e. neurofibromas
